# Heparin for RAO Post-Transradial Angiography in AIS

> **NCT07162064** · PHASE3 · COMPLETED · sponsor: **Xiang Luo** · enrollment: 440 (actual)

## Conditions studied

- Acute Ischemic Stroke

## Interventions

- **DRUG:** Heparin - Therapeutic dosage
- **DRUG:** Saline (0.9% NaCl)

## Key facts

- **NCT ID:** NCT07162064
- **Lead sponsor:** Xiang Luo
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-04
- **Primary completion:** 2026-01-31
- **Final completion:** 2026-02-04
- **Target enrollment:** 440 (ACTUAL)
- **Last updated:** 2026-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07162064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07162064, "Heparin for RAO Post-Transradial Angiography in AIS". Retrieved via AI Analytics 2026-06-16 from https://api.ai-analytics.org/clinical/NCT07162064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*